Daily Dispatch is the owner and publisher of PharmaDispatch, a site dedicated to breaking news and commentary on the Australian pharmaceutical and life sciences sector.
PharmaDispatch is an independent news service providing coverage, opinion and analysis.
The service, which was launched in 2012, aims to provide a new perspective on policy, funding, political and sector specific matters.
Daily Dispatch also publishes BiotechDispatch and HealthDispatch.
PHARMAC: Australia harming cancer patientsJanuary 17, 2018 - Latest News
Pfizer's journey to the Sydney CBDJanuary 17, 2018 - Latest News
Even Senate denied rebate forecastJanuary 17, 2018 - Latest News
FDA approves next step for QIMR Berghofer-developed immunotherapyJanuary 17, 2018 - Latest News
Finance met with PHARMACJanuary 16, 2018 - Latest News
Hospitals take increasing share of PBS spendJanuary 16, 2018 - Latest News
MA executive moving to devicesJanuary 16, 2018 - Latest News